SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* Pellegrino Joseph P JR (Last) (First) (Middle) C/O LEMAITRE VASCULAR, INC. 63 SECOND AVENUE (Street) BURLINGTON MA 01803 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol LEMAITRE VASCULAR INC [ LMAT ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner X Officer (give title below) Other (specify below) Chief Financial Officer
	3. Date of Earliest Transaction (Month/Day/Year) 02/29/2024
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person
	Rule 10b5-1(c) Transaction Indication Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/29/2024		M		3,461(1)	A	$31.3	12,996	D
Common Stock	02/29/2024		M		8,733(1)	A	$23.56	21,729	D
Common Stock	02/29/2024		M		5,883(1)	A	$35.48	27,612	D
Common Stock	02/29/2024		M		5,346(1)	A	$37.29	32,958	D
Common Stock	02/29/2024		M		7,031(1)	A	$48.6	39,989	D
Common Stock	02/29/2024		M		3,430(1)	A	$47.19	43,419	D
Common Stock	02/29/2024		S		1,979	D	$68.56(2)	41,440	D
Common Stock	02/29/2024		S		28,461	D	$69.724(3)	12,979	D
Common Stock	02/29/2024		S		6,250	D	$70.27(4)	6,729	D
Common Stock	02/29/2024		S		277	D	$71.19	6,452	D
Common Stock	02/29/2024		M		2(5)	D	$0(5)	6,450	D
Common Stock	02/29/2024		A		2,649(6)	A	$0(7)	9,099	D
Common Stock	02/29/2024		M		6(8)	A	$0	9,105	D
Common Stock	02/29/2024		F		296(9)	D	$70	8,809	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$31.3	02/29/2024		M			3,461	12/22/2017(10)	12/22/2024	Common Stock	3,461	$0	0	D
Stock Option (Right to Buy)	$23.56	02/29/2024		M			8,733	12/19/2018(10)	12/19/2025	Common Stock	8,733	$0	0	D
Stock Option (Right to Buy)	$35.48	02/29/2024		M			5,883	12/20/2019(11)	12/20/2026	Common Stock	5,883	$0	2,941	D
Stock Option (Right to Buy)	$37.29	02/29/2024		M			5,346	12/02/2020(11)	12/02/2027	Common Stock	5,346	$0	5,345	D
Stock Option (Right to Buy)	$48.6	02/29/2024		M			7,031	12/11/2021(11)	12/11/2028	Common Stock	7,031	$0	7,030	D
Stock Option (Right to Buy)	$47.19	02/29/2024		M			3,430	12/12/2022(11)	12/12/2029	Common Stock	3,430	$0	10,291	D
Dividend Equivalent Rights	(12)	02/29/2024		M			6.683(12)	(12)	(12)	Common Stock	6.683	$0	20.0592	D

Explanation of Responses:

1. Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.

2. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $68.05 to $69.04. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.

3. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $69.05 to $70.045. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.

4. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $70.05 to $70.62. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.

5. Represents shares from the release of fractional dividend equivalent rights returned to company.

6. These shares represent LMAT common stock acquired on February 29, 2024, upon settlement of a Performance Share Unit (PSU) award granted on December 12, 2022. The PSU award vests as follows: 25% upon determination by the Compensation Committee and the balance vests in equal annual installments from the grant date over the next three years.

7. Each PSU represents a contingent right to receive one share of common stock upon vesting based on the attainment of performance goals.

8. Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

9. These shares represent shares withheld by the issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on December 12, 2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.

10. This option is fully vested and exercisable.

11. This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years.

12. These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

	/s/ David C. Hissong	03/04/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.